文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肺结核作为慢性阻塞性肺疾病的一个风险因素:一项系统综述和荟萃分析。

Pulmonary tuberculosis as a risk factor for chronic obstructive pulmonary disease: a systematic review and meta-analysis.

作者信息

Fan Huanhuan, Wu Fan, Liu Jing, Zeng Weifeng, Zheng Silan, Tian Heshen, Li Haiqing, Yang Huajing, Wang Zihui, Deng Zhishan, Peng Jieqi, Zheng Youlan, Xiao Shan, Hu Guoping, Zhou Yumin, Ran Pixin

机构信息

The Third Clinical College, the Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

出版信息

Ann Transl Med. 2021 Mar;9(5):390. doi: 10.21037/atm-20-4576.


DOI:10.21037/atm-20-4576
PMID:33842611
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8033376/
Abstract

BACKGROUND: Prior pulmonary tuberculosis (TB) can cause permanent changes in lung anatomy and is associated with lung function loss. However, it remains unclear whether pulmonary function impairment owing to TB is associated with airflow obstruction, the hallmark of chronic obstructive pulmonary disease (COPD). The aim of this systematic review and meta-analysis was to assess the association and quantify the magnitudes of association between pulmonary TB and COPD, and to evaluate the prevalence of COPD in patients with prior pulmonary TB. METHODS: We searched the PubMed, Embase, and Web of Science databases for studies published from inception to January 1, 2020. Pooled effect sizes were calculated according to a random effects model or fixed effect model depending on heterogeneity. Specific subgroups (different diagnostic criteria, smoking status, income level) were examined. RESULTS: A total of 23 articles were included in this study. Compared with controls, patients with pulmonary TB had an odds ratios (ORs) of 2.59 [95% confidence interval (CI): 2.12-3.15; P<0.001] for developing COPD. In jackknife sensitivity analyses, the increased risk of prior pulmonary TB remained consistent for COPD; when the meta-analysis was repeated and one study was omitted each time, the ORs and corresponding 95% CIs were greater than 2. Funnel plots of ORs with Egger's linear regression (t=2.00, P=0.058) and Begg's rank correlation (Z=0.75, P=0.455) showing no significant publication bias. Subgroup analysis showed that the same conclusion was still present in never smokers (ORs 2.41; 95% CI: 1.74-3.32; P<0.001), patients with pulmonary TB diagnosed using chest X-ray (ORs 2.47; 95% CI: 1.23-4.97; P<0.001), and low- and middle-income country (LMIC) settings (ORs 2.70; 95% CI: 2.08-3.51; P<0.001). The pooled prevalence of COPD in patients with prior pulmonary TB was 21% (95% CI: 16-25%; P<0.001). CONCLUSIONS: Individuals with prior pulmonary TB have an increased risk and high prevalence of COPD. Future studies identifying the underlying mechanisms for TB-associated COPD and therapeutic strategies are required.

摘要

背景:既往肺结核可导致肺部解剖结构发生永久性改变,并与肺功能丧失相关。然而,尚不清楚肺结核所致的肺功能损害是否与气流受限有关,而气流受限是慢性阻塞性肺疾病(COPD)的标志。本系统评价和荟萃分析的目的是评估肺结核与COPD之间的关联,并量化其关联强度,同时评估既往肺结核患者中COPD的患病率。 方法:我们检索了PubMed、Embase和Web of Science数据库,以获取从数据库建立至2020年1月1日发表的研究。根据异质性情况,采用随机效应模型或固定效应模型计算合并效应量。对特定亚组(不同诊断标准、吸烟状况、收入水平)进行了分析。 结果:本研究共纳入23篇文章。与对照组相比,肺结核患者患COPD的比值比(OR)为2.59[95%置信区间(CI):2.12 - 3.15;P<0.001]。在逐一剔除法敏感性分析中,既往肺结核患者患COPD的风险增加仍然一致;每次重复荟萃分析并剔除一项研究时,OR及相应的95%CI均大于2。采用Egger线性回归(t = 2.00,P = 0.058)和Begg秩相关(Z = 0.75,P = 0.455)的OR漏斗图显示无显著发表偏倚。亚组分析表明,从不吸烟者(OR 2.41;95%CI:1.74 - 3.32;P<0.001)、采用胸部X线诊断肺结核的患者(OR 2.47;95%CI:1.23 - 4.97;P<0.001)以及低收入和中等收入国家(LMIC)地区的患者(OR 2.70;95%CI:2.08 - 3.51;P<0.001)中也得出了相同结论。既往肺结核患者中COPD的合并患病率为21%(95%CI:16 - 25%;P<0.001)。 结论:既往有肺结核的个体患COPD的风险增加且患病率较高。未来需要开展研究以确定与肺结核相关的COPD的潜在机制和治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8580/8033376/b543976f1b93/atm-09-05-390-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8580/8033376/2954c4c9b799/atm-09-05-390-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8580/8033376/bc64752911f7/atm-09-05-390-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8580/8033376/bd3d79c34266/atm-09-05-390-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8580/8033376/7bfdd802ffd0/atm-09-05-390-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8580/8033376/f988f96070d8/atm-09-05-390-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8580/8033376/b543976f1b93/atm-09-05-390-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8580/8033376/2954c4c9b799/atm-09-05-390-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8580/8033376/bc64752911f7/atm-09-05-390-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8580/8033376/bd3d79c34266/atm-09-05-390-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8580/8033376/7bfdd802ffd0/atm-09-05-390-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8580/8033376/f988f96070d8/atm-09-05-390-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8580/8033376/b543976f1b93/atm-09-05-390-f6.jpg

相似文献

[1]
Pulmonary tuberculosis as a risk factor for chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Ann Transl Med. 2021-3

[2]
Prevalence of lung cancer in chronic obstructive pulmonary disease: A systematic review and meta-analysis.

Front Oncol. 2022-9-16

[3]
Association between diabetes mellitus and multi-drug-resistant tuberculosis: evidence from a systematic review and meta-analysis.

Syst Rev. 2018-10-15

[4]
A systematic review and meta-analysis-does chronic obstructive pulmonary disease predispose to bronchopleural fistula formation in patients undergoing lung cancer surgery?

J Thorac Dis. 2016-7

[5]
Association of Body Mass Index with Risk of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.

COPD. 2021-2

[6]
Risk Factors for Depression in Tuberculosis Patients: A Meta-Analysis.

Neuropsychiatr Dis Treat. 2022-4-11

[7]
Prevalence of chronic obstructive pulmonary disease at high altitude: a systematic review and meta-analysis.

PeerJ. 2020-4-3

[8]
Association of mild chronic obstructive pulmonary disease with all-cause mortality: A systematic review and meta-analysis.

Pulmonology. 2025-12-31

[9]
Association Between Non-obstructive Chronic Bronchitis and Incident Chronic Obstructive Pulmonary Disease and All-Cause Mortality: A Systematic Review and Meta-Analysis.

Front Med (Lausanne). 2022-1-25

[10]
Effect of alcohol consumption on relapse outcomes among tuberculosis patients: A systematic review and meta-analysis.

Front Public Health. 2022

引用本文的文献

[1]
The prevalence and correlates of obstructive lung disease among adults aged 45 and above in India: Findings from the longitudinal aging study in India.

PLoS One. 2025-8-29

[2]
Pathophysiology, clinical manifestation, and treatment of tuberculosis-associated chronic obstructive pulmonary disease: a narrative review.

Ewha Med J. 2025-4

[3]
Correlation Between Serum Inflammatory Factor Level Changes and Disease Severity in Patients with Chronic Obstructive Pulmonary Disease Complicated by Tuberculosis.

Int J Gen Med. 2025-6-28

[4]
Incidence and Risk Factors of Tuberculosis-Associated Chronic Obstructive Pulmonary Disease.

Int J Chron Obstruct Pulmon Dis. 2025-6-26

[5]
Chronic Obstructive Pulmonary Disease in People with HIV: an Evidence-Based Review.

HIV AIDS (Auckl). 2025-6-12

[6]
Baseline lung function and risk of incident tuberculosis: a nationwide population-based cohort study.

PLoS One. 2025-4-29

[7]
A comparative study on TB incidence and HIVTB coinfection using machine learning models on WHO global TB dataset.

Sci Rep. 2025-4-21

[8]
Variation in Prevalence and Burden of Chronic Obstructive Pulmonary Disease by State and Insurance Type in the United States.

Chronic Obstr Pulm Dis. 2025-3-27

[9]
Advances in the awareness of tuberculosis-associated chronic obstructive pulmonary disease.

Chin Med J Pulm Crit Care Med. 2024-10-18

[10]
Identification of Post-Tuberculosis Lung Function Impairment Early during the Course of Treatment.

Am J Trop Med Hyg. 2024-11-12

本文引用的文献

[1]
Chronic Obstructive Pulmonary Disease Endotypes in Low- and Middle-Income Country Settings: Precision Medicine for All.

Am J Respir Crit Care Med. 2020-7-15

[2]
Inhaled Corticosteroids And Risk Of Tuberculosis In Patients With Obstructive Lung Diseases: A Systematic Review And Meta-Analysis Of Non-randomized Studies.

Int J Chron Obstruct Pulmon Dis. 2019-9-26

[3]
Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease.

N Engl J Med. 2019-9-26

[4]
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Lancet. 2018-11-8

[5]
Inhaled corticosteroids in COPD: friend or foe?

Eur Respir J. 2018-12-13

[6]
Chronic obstructive pulmonary disease in China: a nationwide prevalence study.

Lancet Respir Med. 2018-4-9

[7]
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.

Lancet. 2018-4-9

[8]
Tuberculosis and lung damage: from epidemiology to pathophysiology.

Eur Respir Rev. 2018-2-28

[9]
Prevalence, risk factors and clinical correlates of COPD in a rural setting in Tanzania.

Eur Respir J. 2018-1-31

[10]
The prevalence, burden and risk factors associated with chronic obstructive pulmonary disease in Commonwealth of Independent States (Ukraine, Kazakhstan and Azerbaijan): results of the CORE study.

BMC Pulm Med. 2018-1-30

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索